𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Motexafin gadolinium: a clinical review of a novel radioenhancer for brain tumors

✍ Scribed by Khuntia, Deepak ;Mehta, Minesh

Book ID
115443195
Publisher
Expert Reviews
Year
2004
Tongue
English
Weight
193 KB
Volume
4
Category
Article
ISSN
1473-7140

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A new gadolinium-based contrast agent fo
A new gadolinium-based contrast agent for magnetic resonance imaging of brain tumors: Kinetic study on a C6 rat glioma model
✍ Emmanuel Fonchy; Hana Lahrech; Anne FranΓ§ois-Joubert; Roger Dupeyre; Soraya Bend πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 275 KB πŸ‘ 2 views

## Abstract T~1~‐weighted magnetic resonance imaging (MRI) was used to evaluate the potential interest of a new Gd‐based contrast agent, termed P760, to characterize brain tumor heterogeneity and vascularization and to delineate regions containing permeable vessels. The C6 rat glioma model was used

Clinical evaluation of serum tumor-assoc
Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients
✍ Fiorella Guadagni; Mario Roselli; Teresa Amato; Maurizio Cosimelli; Ernesto Mann πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 491 KB

A novel tumor marker, tumor-associated glycoprotein-72 (TAG-72), has been identified using monoclonal antibody (MAb) B72.3. Using immunohistochemical techniques, TAG-72 has been found in carcinomas of various origin including colon, stomach, breast, lung, prostate, and ovary, as well as in body flui